BackOriginal BioMedicals , Ltd. Overview

Original BioMedicals , Ltd. Receivables

Track Original BioMedicals , Ltd.'s receivables ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$14.40M
↑ 7101.00% YoYΔ $14.20M vs prior year quarter

Peer trimmed avg / median

Loading

Original BioMedicals , Ltd. Receivables History

Loading

Original BioMedicals , Ltd. vs. peers: Receivables Comparison

Loading

Original BioMedicals , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Original BioMedicals , Ltd. (6483.TWO) FAQ

As of the most recent data (June 2026), 6483.TWO shows a receivables of $14M. That compares with $200K in the prior-year period — up 7101.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6483.TWO's receivables is now $14M (was $200K) — a 7101.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Original BioMedicals , Ltd. is outperforming or lagging.

Tracking 6483.TWO's receivables over time shows whether Original BioMedicals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $200K in the prior-year period — up 7101.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Original BioMedicals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $14M) with ownership activity and broader fundamentals.